STOCK TITAN

Interparfums (NASDAQ: IPAR) insider trades 900-share block

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

INTERPARFUMS INC (IPAR) director Veronique Gabai-Pinsky reported option-related transactions in company stock. On 2026-08-27 she exercised options to acquire 900 shares of common stock at an exercise price of $97.84 per share and on the same date sold 900 shares at $116.8586 per share. The filing also lists multiple remaining option-rights to buy common stock with exercise prices between $84.64 and $147.71 expiring between 2028 and 2031.

Positive

  • None.

Negative

  • None.
Insider Gabai-Pinsky Veronique
Role Director
Sold 900 shs ($105K)
Approx. gross sale proceeds $105K
Approx. exercise cost $88K
Approx. pre-tax spread $17K
Type Security Shares Price Value
Exercise Option-right to buy 300 $0.00 $0.00
Exercise Option-right to buy 300 $0.00 $0.00
Exercise Option-right to buy 300 $0.00 $0.00
Exercise Common Stock 900 $97.84 $88K
Sale Common Stock 900 $116.8586 $105K
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Option-right to buy -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Option-right to buy — 5,100 shares (Direct); Common Stock — 0 shares (Direct)
Shares sold 900 shares Common Stock sale on 2026-08-27
Sale price per share $116.8586 per share Common Stock sale of 900 shares on 2026-08-27
Options exercised (underlying shares) 900 shares Exercise of option-rights to buy Common Stock on 2026-08-27
Option exercise price $97.84 per share Option-right to buy Common Stock, expiration 2028-12-30
Net buy/sell shares -900 shares Transaction summary net buy/sell direction net-sell
Remaining option exercise prices $84.64–$147.71 per share Option-rights to buy Common Stock expiring 2028–2031
Option-right to buy financial
"security_title "Option-right to buy" and underlying_security_title "Common Stock""
Exercise or conversion of derivative security financial
"transaction_code_description "Exercise or conversion of derivative security""
derivative security financial
"transaction_type "derivative" with description of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
underlying security financial
"underlying_security_title "Common Stock" for option-right to buy"

FAQ

What did IPAR director Veronique Gabai-Pinsky report in this Form 4?

Veronique Gabai-Pinsky reported exercising options for 900 shares of INTERPARFUMS INC common stock at an exercise price of $97.84 per share and selling 900 shares at $116.8586 per share on 2026-08-27, plus continuing holdings of various option-rights to buy shares.

How many INTERPARFUMS (IPAR) shares were sold and at what price?

The Form 4 shows a sale of 900 shares of INTERPARFUMS INC common stock at a reported price of $116.8586 per share on 2026-08-27. This transaction is coded as a sale of non-derivative common stock.

What was the option exercise price in the IPAR Form 4 transactions?

Options were exercised covering 900 underlying shares of INTERPARFUMS INC common stock at an exercise price of $97.84 per share, with option expirations listed as 2028-12-30 for those exercised tranches.

Does the IPAR Form 4 indicate use of a Rule 10b5-1 trading plan?

The Form 4’s Rule 10b5-1 checkbox is marked false, indicating the reporting of these transactions is not affirmed as being made pursuant to a Rule 10b5-1 trading plan in this filing.

What derivative positions does Veronique Gabai-Pinsky still hold in IPAR?

The filing lists remaining option-rights to buy INTERPARFUMS INC common stock with exercise prices of $97.84, $147.71, $130.60, and $84.64 per share, each linked to 300 underlying shares, with expirations between 2028-12-30 and 2031-12-30.

Is the net effect of this IPAR Form 4 a purchase or sale of shares?

The Form 4 shows options exercised for 900 shares and a sale of 900 shares of common stock, and the transaction summary characterizes the net buy/sell direction as net-sell based on reported buy and sell share counts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gabai-Pinsky Veronique

(Last)(First)(Middle)
200 EAST END AVE

(Street)
NEW YORK NEW YORK 10128

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
INTERPARFUMS INC [ IPAR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock0D
Common Stock08/27/2026M900A$97.84900D
Common Stock08/27/2026S900D$116.85860D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option-right to buy$97.8408/27/2026M30012/31/202312/30/2028Common Stock300$00D
Option-right to buy$97.8408/27/2026M30012/31/202412/30/2028Common Stock300$00D
Option-right to buy$97.8408/27/2026M30012/31/202512/30/2028Common Stock300$00D
Option-right to buy$97.8412/31/202612/30/2028Common Stock300300D
Option-right to buy$97.8412/31/202712/30/2028Common Stock300300D
Option-right to buy$147.7112/29/202412/28/2029Common Stock300300D
Option-right to buy$147.7112/29/202512/28/2029Common Stock300300D
Option-right to buy$147.7112/29/202612/28/2029Common Stock300300D
Option-right to buy$147.7112/29/202712/28/2029Common Stock300300D
Option-right to buy$147.7112/29/202812/28/2029Common Stock300300D
Option-right to buy$130.612/31/202512/30/2030Common Stock300300D
Option-right to buy$130.612/31/202612/30/2030Common Stock300300D
Option-right to buy$130.612/31/202712/30/2030Common Stock300300D
Option-right to buy$130.612/31/202812/30/2030Common Stock300300D
Option-right to buy$130.612/31/202912/30/2030Common Stock300300D
Option-right to buy$84.6412/31/202612/30/2031Common Stock300300D
Option-right to buy$84.6412/31/202712/30/2031Common Stock300300D
Option-right to buy$84.6412/31/202812/30/2031Common Stock300300D
Option-right to buy$84.6412/31/202912/30/2031Common Stock300300D
Option-right to buy$84.6412/31/203012/30/2031Common Stock300300D
Explanation of Responses:
/s/ Veronique Gabai-Pinsky by Joseph A. Caccamo, as attorney-in-fact08/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)